13F Filings/FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC

Hedge FundCIK0000909661LocationSAN FRANCISCO, CA 94111, United States

Long U.S. equity positions disclosed to the SEC on Form 13F-HR.

Latest filingQ1 2026Quarter ended31 Mar 2026Filed15 May 2026
Firm profile · Form ADV
SEC adviser registration
CRD
138713 · 801-65852
Portfolio Turnover
Of book traded, QoQ
Positions
172
Long U.S. equities
Top 10 Concentration
49%
Of reported value
QoQ Change
Value change
Assets under management
Form ADV RAUM · client mix · 13F over time
Regulatory AUM
$4.1B
Form ADV, as of Jun 2024
100% discretionary ($4.1B)
By client type
Pooled investment vehicles: $4.1B (100.0%) · 67 clients
Pooled investment vehicles
$4.1B · 100%
13F AUM over time
$17.5B
Q1 ’26 · 13F AUM
236%
52 quarters
Showing the last 5 years of filings. Want this fund’s full history back to inception?
Reported Holdings
★ Position spotlightCGONCG ONCOLOGY INC · 0.3% of book
🔒
See how this position changed across every quarter
Multi-quarter 13F position history — shares held, buys & sells, and price over time — is a Pro feature. The latest snapshot below stays free.
SecuritySharesMarket ValueEst. CostLast PxEst. Return% PortfolioΔ SharesAction
STATE STR SPDR S&P 500 ETF T
2.30MPut$1.5B8.5%NewNew
REVOLUTION MEDICINES INC
13.60MSH$1.3B~$97.257.5%NewNew
AMAZON COM INC
4.22MSH$878.6M~$208.275.0%NewNew
MICROSOFT CORP
2.34MSH$868.0M~$370.174.9%NewNew
AON PLC
2.51MSH$811.0M~$322.784.6%NewNew
BRIDGEBIO PHARMA INC
9.37MSH$695.5M~$74.264.0%NewNew
INVESCO EXCHANGE TRADED FD T
3.60MPut$690.9M3.9%NewNew
PROTAGONIST THERAPEUTICS INC
6.35MSH$669.2M~$105.403.8%NewNew
NATERA INC
3.21MSH$641.4M~$199.993.7%NewNew
EXELIXIS INC
13.11MSH$562.3M~$42.893.2%NewNew
STATE STR SPDR S&P 500 ETF TNew
$1.5B· 8.5%· 2.30M Put· New
TR UNIT · OTR
REVOLUTION MEDICINES INCNew
$1.3B· 7.5%· 13.60M SH· New· cost $97.25
COM · OTR
AMAZON COM INCNew
$878.6M· 5.0%· 4.22M SH· New· cost $208.27
COM · OTR
MICROSOFT CORPNew
$868.0M· 4.9%· 2.34M SH· New· cost $370.17
COM · OTR
AON PLCNew
$811.0M· 4.6%· 2.51M SH· New· cost $322.78
SHS CL A · OTR
BRIDGEBIO PHARMA INCNew
$695.5M· 4.0%· 9.37M SH· New· cost $74.26
COM · OTR
INVESCO EXCHANGE TRADED FD TNew
$690.9M· 3.9%· 3.60M Put· New
S&P500 EQL WGT · OTR
PROTAGONIST THERAPEUTICS INCNew
$669.2M· 3.8%· 6.35M SH· New· cost $105.40
COM · OTR
NATERA INCNew
$641.4M· 3.7%· 3.21M SH· New· cost $199.99
COM · OTR
EXELIXIS INCNew
$562.3M· 3.2%· 13.11M SH· New· cost $42.89
COM · OTR
110 of 172
1 / 18
Sector Breakdown
Q1 2026
Unclassified100.0% · $17.5B